TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan · Delayed Price · Currency is TWD 54.40
-0.40 (-0.73%)
Oct 17, 2025, 12:59 PM CST
TSH Biopharm Corporation Market Cap
TSH Biopharm Corporation has a market cap or net worth of 2.09 billion as of October 17, 2025. Its market cap has decreased by -3.37% in one year.
Market Cap
2.09B
Enterprise Value
1.43B
Revenue
1.24B
Ranking
n/a
PE Ratio
18.26
Stock Price
54.40
Market Cap Chart
Since June 16, 2011, TSH Biopharm Corporation's market cap has increased from 1.96B to 2.09B, an increase of 6.45%. That is a compound annual growth rate of 0.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 2.09B | -11.26% |
| Dec 31, 2024 | 2.35B | 21.87% |
| Dec 29, 2023 | 1.93B | 5.78% |
| Dec 30, 2022 | 1.83B | 6.85% |
| Dec 30, 2021 | 1.71B | -24.45% |
| Dec 31, 2020 | 2.26B | -24.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 251.26B |
| PharmaEssentia | 190.83B |
| Bora Pharmaceuticals Co., LTD. | 80.18B |
| Lotus Pharmaceutical | 78.76B |
| Lumosa Therapeutics | 48.85B |
| Oneness Biotech | 30.37B |
| Polaris Group | 27.74B |
| Center Laboratories | 25.27B |